Skip to main content
Topic

SGLT2

SGLT2 Inhibitors

SGLT2 inhibitors are diabetes medications that work by making your kidneys excrete excess glucose through urine rather than reabsorbing it back into the bloodstream. While effective at lowering blood sugar, they carry a small risk of diabetic ketoacidosis—especially when combined with very low-carb diets. If you're taking SGLT2 inhibitors (like Farxiga, Jardiance, or Invokana) and considering low-carb eating, close medical supervision is essential to monitor ketone levels and adjust medication safely.

  Article (1)